Aromatase inhibitors (letrozole) for infertile women with polycystic ovary syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aromatase Inhibitors (letrozole) for Infertile Women With Polycystic Ovary Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305236/all/Aromatase_inhibitors__letrozole__for_infertile_women_with_polycystic_ovary_syndrome.
Aromatase inhibitors (letrozole) for infertile women with polycystic ovary syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305236/all/Aromatase_inhibitors__letrozole__for_infertile_women_with_polycystic_ovary_syndrome. Accessed December 6, 2024.
Aromatase inhibitors (letrozole) for infertile women with polycystic ovary syndrome. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305236/all/Aromatase_inhibitors__letrozole__for_infertile_women_with_polycystic_ovary_syndrome
Aromatase Inhibitors (letrozole) for Infertile Women With Polycystic Ovary Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305236/all/Aromatase_inhibitors__letrozole__for_infertile_women_with_polycystic_ovary_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aromatase inhibitors (letrozole) for infertile women with polycystic ovary syndrome
ID - 1305236
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305236/all/Aromatase_inhibitors__letrozole__for_infertile_women_with_polycystic_ovary_syndrome
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -